Transforming Biopharma

Resetting how we think about obesity: A patient’s point of view

ZS

Recent headlines about the use of prescription drugs for weight loss make obesity a prominent and relevant topic in today’s discussions about health and well-being. Bill Coyle, ZS’s global head of biopharma, and Mandi White-Ajmani, Ph.D., clinical psychologist and owner, Small Brooklyn Psychology, join Maria Whitman to talk about the underlying challenges obesity presents to society and healthcare, even as new treatments emerge.